Massachusetts Life Sciences Center announces capital funding to support innovation infrastructure- HMS Center for Glycoscience, NCFG, Glycomics Core recipients of funds

March 4, 2022

Massachusetts Life Sciences Center awards HMS Center for Glycoscience, the NCFG and the Glycomics Core at BIDMC $1.4 million for project titled " Innovative Glycoscience for Diagnostic and Therapeutic Advances". 

“This incredible support by the Massachusetts Life Sciences Center is vital to the development of glycosciences and medical advances in this area,” said Richard D. Cummings, PhD, Director of the HMS Center for Glycoscience at BIDMC. “The key resources to be provided by the funds will be transformative to not only our team but will aid researchers and companies throughout the commonwealth.”

Click here for full article.